Compare NVST & FSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVST | FSK |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | 12000 | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.2B |
| IPO Year | 2019 | 2008 |
| Metric | NVST | FSK |
|---|---|---|
| Price | $26.28 | $10.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 8 |
| Target Price | ★ $25.33 | $13.94 |
| AVG Volume (30 Days) | 2.1M | ★ 5.2M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 20.16% |
| EPS Growth | ★ 104.31 | N/A |
| EPS | ★ 0.28 | 0.04 |
| Revenue | ★ $2,566,500,000.00 | N/A |
| Revenue This Year | $6.67 | N/A |
| Revenue Next Year | $3.55 | N/A |
| P/E Ratio | ★ $88.86 | $248.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.22 | $9.72 |
| 52 Week High | $30.42 | $22.68 |
| Indicator | NVST | FSK |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 32.08 |
| Support Level | $19.29 | N/A |
| Resistance Level | $30.18 | $15.19 |
| Average True Range (ATR) | 0.95 | 0.33 |
| MACD | -0.18 | 0.07 |
| Stochastic Oscillator | 44.78 | 26.45 |
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
FS KKR Capital Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.